For normal healthy hearts, its values range from 2.01±0.72 (4) to 5.16±1.64 (5) , or even to 6.10±1.64 (6) , all studies performed with 15 
Reconstruction
There are three key reasons for the differences in the input images: (1) temporal sampling, (2) reconstruction methods,
and (3) 
Quality control
The problems at this step are (1) motion in a blood pool phase and (2) manual motion correction. The first problem is patient motion that is prevalent in dynamic PET̶up to 62%
of datasets with majority 45% in the axial direction and it affects mean estimates of MBF up to 250% (27) . The models conventionally used are compartmental models.
The differences between these models highlight the trade-off between model accuracy and precision which in practice means that estimates provided by more complex and realistic models like Axially distributed (29) and 2TCM will generally have higher variance than those of the simpler 1TCMs (30) .
The Retention model is the simplest of these models that assumes washout can be neglected. It is defined as the ratio of the average late tissue activity over the total early blood pool activity within a predefined time interval, which requires consistent tracer arrival time into LV blood pool (31) . The above models all assume that the LV blood pool TAC is a true signal, which is not the case due to partial volume effects. For large LV blood pool ROIs placed in the LV cavity, the tissue activity will spillover into the blood pool. This is seen in the tail of the blood TAC where the activity does not seem to clear the blood. Two proposed solutions are to implement dualspillover correction (32, 33) or place a smaller ROI in the left atrium outside LV cavity (23) .
Outputting the values
The main problem at this step is the MBF variability due to (28, 38) , is to find a common denominator for the existing tools. In practice, it means the following: we doubt that it is currently feasible to single out 'the one' software solution, make everyone let go the tools they have been using for years already and switch to that one tool. What is feasible, however, is to test all the tools on common datasets, find out where each of the tools stands in respect to the rest and use these results in pooling and communicating the data. We are performing it for all the nuclear cardiology tracers.
Nonetheless, this way we see as a temporary substitute and consider the third way the most likely future. The third way is to support emergence and perfection of the software and the underpinning algorithms̶of reorientation, segmentation, motion correction, etc.̶which would ultimately lead to the survival of the fittest tools for PET MPQ that in the long run will converge on the most accurate and precise values.
Nobody can guarantee though that in the same long run the survivors, which will measure myocardial blood flow accurately and sparingly, will be the software tools analyzing images of PET.
